Collegium Pharmaceutical Inc
COLLHealthcare|Drug Manufacturers - Specialty & Generic|USA
$35.22
-0.59 (-1.65%)
DCF (FCF)
$54.10
Earnings Power
$22.35
Upcoming Data Readouts (2)
Nov 2026
Est. completion
IBD and Renal Involement
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
NCT07593352n=6,000
Apr 2028
Est. completion
NAACL Injury
The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.
NCT06442319n=60